Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-01-04
2011-01-04
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S112000
Reexamination Certificate
active
07863290
ABSTRACT:
The invention relates to compounds having general formula (I), wherein R is as defined herein.The invention also relates to acid addition salt, a hydrate or a solvate of compounds of formula (I). The invention further relates to the method of preparing said compounds and to the use of same in therapeutics.
REFERENCES:
patent: 5817679 (1998-10-01), Shen et al.
patent: 7223750 (2007-05-01), Galli et al.
patent: 0664293 (1995-07-01), None
patent: WO 98/54181 (1998-12-01), None
patent: 03/057697 (2003-07-01), None
patent: WO 03/057697 (2003-07-01), None
Holladay, M. W., et. al., Neuronal Nicotinic Acetylchloline Receptors as Targets for Drug Discovery, Journal of Medicnal Chemistry, vol. 40, No. 26, (1997) pp. 4169-4194.
Galli Frederic
Leclerc Odile
Lochead Alistair
Vache Julien
Balaram Gupta
Bender Kelly L.
Rahmani Niloofar
Sanofi-Aventis
Seaman D. Margaret
LandOfFree
Derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2694952